Drug-Drug Interactions (DDIs) in Elderly Hypertensive Inpatients

Arina Titami(1*), Chairun Wiedyaningsih(2), I Dewa Putu Pramantara(3)
(1) Universitas Jenderal Achmad Yani Yogyakarta
(2) Universitas Gadjah Mada
(3) Universitas Gadjah Mada
(*) Corresponding Author
Abstract
Background: The prevalence of hypertension is higher among the elderly population. Elderly patients are considered a high-risk population for Drug-Drug Interactions (DDIs) due to multi-morbidity-related polypharmacy, age-related physiological changes, as well as pharmacokinetic and pharmacodynamic changes.
Objectives: This study conducted a drug use survey in the inpatient department of the Academic Hospital of Universitas Gadjah Mada Yogyakarta to assess Drug-drug interactions (DDIs) in individual prescriptions for elderly hypertensive patients.
Methods: This research employs an observational study design with a retrospective cohort approach. This study was conducted at the Academic Hospital of Universitas Gadjah Mada Yogyakarta in January-December, 2021. The inclusion criteria for this study included patients diagnosed with hypertension, aged 60 years or older and those hospitalized. Ethical approval for this research was granted by the Faculty of Medicine, Public Health and Nursing Research Ethics Commission at Universitas Gadjah Mada, Yogyakarta under approval number KE-FK-0500-EC-2022.
Results: 120 prescriptions from 120 patients were collected from the medical records maintained by the Academic Hospital of Universitas Gadjah Mada Yogyakarta. This study identified 66 cases of Drug-Drug Interactions (DDIs), mainly due to drug interactions comprising 8 interactions unrelated to hypertension, and 58 related to hypertension. Three actual drug interaction events resulted in increased blood pressure, while the others were potential drug interactions.
Conclusion: From this study, it can be concluded that elderly patients are considered a natural high-risk population for DDIs. Each patient should be assessed individually based on their prescriptions, although in many cases, DDIs are unavoidable.
Keywords: Drug-Drug Interactions; Elderly; Hypertension; InpatientsKeywords
References
DiPiro JT, Wells BG, Schwinghammer TL, DiPiro C V. Pharmacotherapy Handbook,11th Edition.; 2021.
Badan Penelitian dan Pengembangan Kesehatan -. Laporan Nasional Riskesdas 2018. Lembaga Penerbit Balitbangkes. Published online 2018:156. Accessed November 1, 2024. https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan Riskesdas 2018 Nasional.pdf
Titami A, Wiedyaningsih C, Pratama IDP. Profil Penggunaan Obat Antihipertensi Pada Pasien Lanjut Usia Yang Dirawat Inap RS Akademik UGM. Majalah Farmaseutik. 2023;19(3):355-360. doi:10.22146/farmaseutik.v19i3.78446
Hailu BY, Berhe DF, Gudina EK, Gidey K, Getachew M. Drug related problems in admitted geriatric patients: The impact of clinical pharmacist interventions. BMC Geriatr. 2020;20(1). doi:10.1186/s12877-020-1413-7
Crisafulli S, Poluzzi E, Lunghi C, et al. Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective. Frontiers in Drug Safety and Regulation. 2022;2. doi:10.3389/fdsfr.2022.1011701
Harężlak T, Religioni U, Szymański FM, et al. Drug Interactions Affecting Kidney Function: Beware of Health Threats from Triple Whammy. Adv Ther. 2022;39(1). doi:10.1007/s12325-021-01939-9
Saraswati MD, Ardiana SM, Suprapti B, Assegaf MY, Suharjono S, Hamidah KF. Potential Drug–Drug Interactions in Ambulatory Patients with Hypertension: a Retrospective Study. JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA. 2022;9(1). doi:10.20473/jfiki.v9i12022.69-74
Muzammil M, Hussain SS. Drug-Drug Interaction between Non-Steroidal Anti-Inflammatory and Angiotensin Receptor Blocker. National Journal of Health Sciences. 2021;6(2):88-89. doi:10.21089/njhs.62.0088
Fravel MA, Ernst M. Drug Interactions with Antihypertensives. Curr Hypertens Rep. 2021;23(3). doi:10.1007/s11906-021-01131-y
Saraswati MD, Ardiana SM, Suprapti B, Assegaf MY, Suharjono S, Hamidah KF. Potential Drug–Drug Interactions in Ambulatory Patients with Hypertension: a Retrospective Study. JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA. 2022;9(1):69-74. doi:10.20473/jfiki.v9i12022.69-74
Roni RK, Ulfa AM, Rudy M. POTENSI INTERAKSI OBAT ANTIHIPERTENSI DI PUSKESMAS PINANG JAYA MENGGUNAKAN METODE OBSERVASI. Jurnal Ilmu Kedokteran dan Kesehatan. 2023;10(11):3281-3293. Accessed November 1, 2024. https://ejurnalmalahayati.ac.id/index.php/kesehatan/article/view/11163
Maria N, Susilo FV, Simarmata M. Drug Selection, Dosage Adjustment, and Potential Interaction of Antihypertensive and Antidiabetic for Chronic Kidney Disease with Hemodialysis. JURNAL ILMU KEFARMASIAN INDONESIA. 2023;21(2). doi:10.35814/jifi.v21i2.1484
Claire LP. Stockley’s Drug Interactions 2015.; 2015.
Sugiyono, Padmasari S. HUBUNGAN KESESUAIAN ANTIBIOTIK DEFINITIF DENGAN CLINICAL OUTCOME PADA PASIEN ULKUS DIABETIK DI RSUD KOTA YOGYAKARTA. FITOFARMAKA: JURNAL ILMIAH FARMASI. 2019;9(1):56-63. https://journal.unpak.ac.id/index.php/fitofarmaka/article/view/1261
Mohamed Pakkir Maideen N, Balasubramanian R, Muthusamy S, Nallasamy V. An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers. Curr Cardiol Rev. 2022;18(6). doi:10.2174/1573403x18666220511152330
Miano TA, Shashaty MGS, Yang W, Brown JR, Zuppa A, Hennessy S. Effect of Renin-Angiotensin System Inhibitors on the Comparative Nephrotoxicity of NSAIDs and Opioids during Hospitalization. Kidney360. 2020;1(7). doi:10.34067/KID.0001432020
Fukushima S, Oishi M, Aso H, et al. Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis. European Journal of Hospital Pharmacy. 2021;30(4):208. doi:10.1136/EJHPHARM-2021-002739
Yuswar MA, Rachmadani E, Untari EK. IDENTIFIKASI DAMPAK INTERAKSI OBAT ANTIHIPERTENSI TERHADAP TEKANAN DARAH PADA PASIEN GERIATRI HIPERTENSI YANG DIRAWAT INAP DI RSUD DR SOEDARSO PONTIANAK. Jurnal Ilmiah Manuntung. 2022;8(1):163-172. doi:10.51352/JIM.V8I1.524
Anjeline M, Uko J, Virginia DM. Drug Interaction Study of Antihypertension in Geriatric Patients Diagnosed Hypertension at Puskesmas Mauponggo, Nusa Tenggara Timur. Majalah Farmaseutik. 2024;20(2):167-173. doi:10.22146/farmaseutik.v20i2.84773

Article Metrics

Refbacks
- There are currently no refbacks.
Copyright (c) 2025 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
